MetaCap

Tectonic Therapeutic Inc. Company Profile

NASDAQ: TECXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

20.73-0.31 (-1.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tectonic Therapeutic at a glance

Tectonic Therapeutic Inc. (NASDAQ: TECX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Watertown, MA. Tectonic Therapeutic is led by Dr. Alise S. Reicin M.D., Ph.D. and employs about 60 people. The company's shares have traded publicly since 2018.

At a market capitalization of $405.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001681087, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Tectonic Therapeutic do?

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Tectonic Therapeutic Inc.
Ticker
NASDAQ: TECX
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Alise S. Reicin M.D., Ph.D.
Employees
60
Headquarters
490 Arsenal Way, Watertown, MA, United States
Phone
339 666 3320
IPO year
2018
Market cap
$405.26M
SEC CIK
0001681087
Latest annual report
10-K · Feb 26, 2026

Companies similar to Tectonic Therapeutic

TECX peer companies
CompanyPrice% ChgMarket capCompare
TVGNTevogen Inc.5.90-6.35%$405.20Mvs TECX
CADLCandel Therapeutics Inc.5.04-1.75%$395.37Mvs TECX
PROKProKidney Corp. Class A1.04-1.89%$415.21Mvs TECX
IRLAIRulya Therapeutics Inc.39.88-0.15%$432.36Mvs TECX
FENCFennec Pharmaceuticals Inc.13.09-2.68%$462.14Mvs TECX
ALECAlector Inc.2.34+1.52%$347.63Mvs TECX
RGNXREGENXBIO Inc.7.16-0.28%$473.44Mvs TECX
SANASana Biotechnology Inc.1.59-8.62%$476.42Mvs TECX

Related